
Henry Schein Inc
HSICHenry Schein Inc (HSIC) is a global provider of healthcare products and services, primarily serving dental, medical, and veterinary practitioners. The company offers dental equipment, consumables, pharmaceuticals, and technology solutions, supporting healthcare professionals in delivering quality patient care. Established in 1932, Henry Schein has built a reputation as a comprehensive distributor and service provider in the healthcare industry.
Company News
The global clear aligners market is valued at $11.23 billion in 2026 and is expected to grow to $99.44 billion by 2034, expanding at a 31.34% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Adults dominate by age segment, polyurethane leads by material type, and online distribution channels are expected to grow f...
The global invisible orthodontics market is projected to grow from USD 9.91 billion in 2025 to USD 96.27 billion by 2034, expanding at a CAGR of 28.54%. Clear aligners dominate the product segment, with North America leading regionally and Asia-Pacific showing significant growth potential. Adults currently represent the largest age segment, while...
A comprehensive market report on the U.S. Personal Protective Equipment market covering gowns, masks, face shields, gloves and other segments through 2033. The report provides revenue, volume, and pricing data across market segments with company share information for 2024, identifying key opportunities for market entry, expansion, and investment ...
The global sleeping bruxism treatment market is projected to grow from USD 652.14 million in 2025 to USD 1,132.09 million by 2033, expanding at a 7.18% CAGR. Growth is driven by rising awareness of sleep disorders, increasing stress levels, and demand for oral appliances and behavioral therapies. Occlusal splints and night guards dominate the mar...
Zuckerman Investment Group increased its Henry Schein stake by 72,040 shares in Q3, bringing its position to 281,339 shares valued at $18.67 million. The purchase reflects confidence in Henry Schein's improving fundamentals, including 5% revenue growth to $3.3 billion, 13% non-GAAP EPS growth to $1.38, and a new $200 million efficiency plan. The ...
Related Companies









